Development and alpha testing of a decision aid for individuals with newly diagnosed obstructive sleep apnea

Obstructive sleep apnea (OSA) is an increasingly prevalent disorder associated with serious health risks. Although discussing treatment options with healthcare providers is recommended before initiating therapy, such shared decision making (SDM) is not yet widely practiced. Decision aids (DAs) are effective tools for facilitating SDM, but no DA has been developed for OSA treatment in Japan. This study aimed to develop a DA to help individuals newly diagnosed with OSA choose a treatment option consistent with their personal values and to evaluate its acceptability among both patients and healthcare providers. A DA was systematically developed in accordance with the International Patient Decision Aid Standards. First, a prototype was created on the basis of evidence from the 2020 Clinical Practice Guideline for Sleep Apnea Syndrome. Second, alpha acceptability testing was conducted via a mixed-methods questionnaire administered to patients and healthcare providers. Feedback, including free-text qualitative comments, was incorporated to refine the prototype and produce a final version suitable for clinical use. The 28-page DA consisted of a description of OSA; the available treatment options—(i) continuous positive airway pressure, (ii) oral appliance, (iii) weight loss, and (iv) side sleeping; the advantages and disadvantages of each option; and value clarification exercises for each option. Patients ( n = 18) reported that the DA had appropriately concise sentences (89%), adequate information (94%), and a well-balanced presentation (100%) and was useful in deciding which treatment option to choose for OSA (94%). Healthcare providers ( n = 21) also provided favourable feedback. On the basis of the acceptability assessment, the prototype was refined to produce a final version suitable for clinical use. A DA to support treatment choices for OSA, specifically developed for use during the SDM process, was successfully created. Further research is warranted to evaluate its impact on decision quality and patient outcomes.

Authors

Institutions

Publication Details

Journal
BMC Medical Informatics and Decision Making
Published
2026-11-18
DOI
https://doi.org/10.1186/s12911-026-03980-6
Primary Topic
Patient-Provider Communication in Healthcare
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Development and alpha testing of a decision aid for individuals with newly diagnosed obstructive sleep apnea

Yasunori Oka, Yumi Aoki, Yoko Fujino, Yoshikazu Takaesu et al.
BMC Medical Informatics and Decision Making
Patient-Provider Communication in Healthcare
article

Development and alpha testing of a decision aid for individuals with newly diagnosed obstructive sleep apnea

Yasunori Oka, Yumi Aoki, Yoko Fujino, Yoshikazu Takaesu, Kazuo Mishima, Hideaki Nakayama, Takatoshi Kasai
article en

Abstract

Obstructive sleep apnea (OSA) is an increasingly prevalent disorder associated with serious health risks. Although discussing treatment options with healthcare providers is recommended before initiating therapy, such shared decision making (SDM) is not yet widely practiced. Decision aids (DAs) are effective tools for facilitating SDM, but no DA has been developed for OSA treatment in Japan. This study aimed to develop a DA to help individuals newly diagnosed with OSA choose a treatment option consistent with their personal values and to evaluate its acceptability among both patients and healthcare providers. A DA was systematically developed in accordance with the International Patient Decision Aid Standards. First, a prototype was created on the basis of evidence from the 2020 Clinical Practice Guideline for Sleep Apnea Syndrome. Second, alpha acceptability testing was conducted via a mixed-methods questionnaire administered to patients and healthcare providers. Feedback, including free-text qualitative comments, was incorporated to refine the prototype and produce a final version suitable for clinical use. The 28-page DA consisted of a description of OSA; the available treatment options—(i) continuous positive airway pressure, (ii) oral appliance, (iii) weight loss, and (iv) side sleeping; the advantages and disadvantages of each option; and value clarification exercises for each option. Patients ( n = 18) reported that the DA had appropriately concise sentences (89%), adequate information (94%), and a well-balanced presentation (100%) and was useful in deciding which treatment option to choose for OSA (94%). Healthcare providers ( n = 21) also provided favourable feedback. On the basis of the acceptability assessment, the prototype was refined to produce a final version suitable for clinical use. A DA to support treatment choices for OSA, specifically developed for use during the SDM process, was successfully created. Further research is warranted to evaluate its impact on decision quality and patient outcomes.

BMC Medical Informatics and Decision Making
Tokyo Medical University (JP), Akita University (JP), University of the Ryukyus (JP), Juntendo University (JP), St. Luke's International University (JP), Tokyo Medical University Hospital (JP), Ehime University Hospital (JP)
Japan Society for the Promotion of Science
Good health and well-being
Patient-Provider Communication in Healthcare
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon